Intravenous ketorolac vs NSAIDs
Number of participants experiencing any serious adverse events · adults (mean study ages 23 to 67 years) with acute postoperative pain after abdominal/pelvic, dental or orthopedic surgeries
Intravenous ketorolac showed no clear difference in number of participants experiencing a serious adverse event compared with another NSAID (low certainty).
1 finding from 1 review
- Single‐dose intravenous ketorolac for acute postoperative pain in adults 2021 · Cochrane Headline outcomes onlyRR 3.18 [0.13, 76.99]5 studies · 530 participantsLow